PF-05212377 for People with Alzheimer's Disease and Neuropsychiatric Symptoms

Language Undefined Purpose: To evaluate safety and efficacy of the experimental drug PF-05212377 in people with mild to moderate Alzheimer's disease and neuropsychiatric symptoms who take donepezil.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: Source Type: clinical trials